Table 1 Clinical characteristics of 19 patients with malignant progression and their classification process
No. | DWI volume (ml) | CTbaseline to malignant progression (hr) | Classification process | Decompression | 3 m mRS |
|---|---|---|---|---|---|
1 | 124 | 9.4 | Pupillary changes | N | 6 |
2 | 125 | 17.8 | Pupillary changes | Y | 6 |
3 | 129 | 21.2 | Imaging based decision | Y | 3 |
4 | 96 | 17.4 | Pupillary changes | N | 6 |
5 | 116 | 8.5 | Pupillary changes | N | 6 |
6 | 148 | 149.8 | Pupillary changes | N | 6 |
7 | 179 | 96.0 | Pupillary changes | Y | 5 |
8 | 218 | 28.9 | Pupillary changes | Y | 5 |
9 | 232 | 46.4 | Pupillary changes | Y | 4 |
10 | 244 | 13.3 | Pupillary changes | N | 6 |
11 | 304 | 19.7 | Pupillary changes | Y | 5 |
12 | 308 | 5.6 | Imaging based decision | N | 6 |
13 | 319 | 4.0 | Coma | Y | 6 |
14 | 364 | 13.2 | Pupillary changes | N | 6 |
15 | 391 | 7.8 | Pupillary changes | Y | 6 |
16 | 475 | 5.4 | Imaging based decision | Y | 6 |
17 | 343 | 5.4 | Imaging based decision | Y | 4 |
18 | 155 | 21.0 | Pupillary changes | N | 6 |
19 | 227 | 7.0 | Pupillary changes | N | 6 |